Fierce Biotech Fundraising Tracker ’26: Sole looks at $200 million Series C; Rakuten earns $100 millionfierce biotech
Exclusive: Solé emerges with $200M Series C and extensive pipeline for ‘stress clock’endpoint news
Sole Therapeutics raises $200 million in Series C financingfinsme
Sole Therapeutics Announces $200 Million Series C Financing to Lead Oncology Programs in the Clinic and Scale Its Cell Stress Sensing Platformyahoo finance
Wilson Sonsini advised Sole Therapeutics on $200 million Series C financingWilson Sonsini